Neutrophil gelatinase-associated lipocalin (NGAL) and tumor necrosis factor-α(TNF-α) levels in patients with schizophrenia
Introduction Although the immune system is thought to contribute to the etiology of schizophrenia, the mechanism has not been clearly elucidated. Clarifying the relationship between them is important in terms of diagnosis, treatment, and prevention approaches. Objectives In this study, it is aimed...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Cambridge University Press
2023-03-01
|
| Series: | European Psychiatry |
| Online Access: | https://www.cambridge.org/core/product/identifier/S0924933823005825/type/journal_article |
| _version_ | 1827753943497703424 |
|---|---|
| author | A. Gül Çakıl H. Kaya A. Sakallı Nural I. B. Çakmak I. T. Okay E. Göka |
| author_facet | A. Gül Çakıl H. Kaya A. Sakallı Nural I. B. Çakmak I. T. Okay E. Göka |
| author_sort | A. Gül Çakıl |
| collection | DOAJ |
| description |
Introduction
Although the immune system is thought to contribute to the etiology of schizophrenia, the mechanism has not been clearly elucidated. Clarifying the relationship between them is important in terms of diagnosis, treatment, and prevention approaches.
Objectives
In this study, it is aimed to determine whether there is any difference in serum levels of neutrophil gelatinase-associated lipocalin (NGAL) and tumor necrosis factor-alpha (TNF-α) in the group of patients with schizophrenia and healthy volunteers, whether these values are changed by medical treatment, whether there is any relation between these values and the severity of the symptoms of patients with schizophrenia, and whether NGAL can be used as a biomarker in the diagnosis and the follow-up of the schizophrenia.
Methods
A total of 64 patients who were hospitalized in the Psychiatry Clinic of Xxxxxx and diagnosed with schizophrenia and 55 healthy volunteers were included in the study. A sociodemographic information form was given to all participants and TNF-α and NGAL values were measured. Positive and Negative Symptoms Rating Scale (PANSS) were applied to the schizophrenia group on admission and follow-up. TNF-α and NGAL levels were re-measured in the 4th week after the start of antipsychotic treatment.
Results
As a result of the present study, it was found that NGAL levels decreased significantly after antipsychotic treatment of schizophrenia patients hospitalized with exacerbation (Figure 1). There was no significant correlation between NGAL and TNF-α levels among schizophrenia and the control group.
Image:
Conclusions
In psychiatric diseases, especially schizophrenia, there may be differences in immune and inflammatory markers compared to the healthy population. After treatment, the NGAL levels of the patients at follow-up were reduced in comparison with the levels at their admission. It can be thought that NGAL may be related to psychopathology in schizophrenia and antipsychotic treatment. This is the first followup study for NGAL levels in schizophrenia.
Disclosure of Interest
A. Gül Çakıl Grant / Research support from: This study funded by the Turkish Republic SBU Scientific Research Projects Coordinatorship. (Project no: 2020/013), H. Kaya: None Declared, A. Sakallı Nural: None Declared, I. Çakmak: None Declared, I. Okay: None Declared, E. Göka: None Declared |
| first_indexed | 2024-03-11T07:42:20Z |
| format | Article |
| id | doaj.art-9f9f989990664c67aa38d6f68ed1bb57 |
| institution | Directory Open Access Journal |
| issn | 0924-9338 1778-3585 |
| language | English |
| last_indexed | 2024-03-11T07:42:20Z |
| publishDate | 2023-03-01 |
| publisher | Cambridge University Press |
| record_format | Article |
| series | European Psychiatry |
| spelling | doaj.art-9f9f989990664c67aa38d6f68ed1bb572023-11-17T05:08:17ZengCambridge University PressEuropean Psychiatry0924-93381778-35852023-03-0166S254S25410.1192/j.eurpsy.2023.582Neutrophil gelatinase-associated lipocalin (NGAL) and tumor necrosis factor-α(TNF-α) levels in patients with schizophreniaA. Gül Çakıl0H. Kaya1A. Sakallı Nural2I. B. Çakmak3I. T. Okay4E. Göka51Psychiatry, Bolu Mental Health Hospital, Bolu2Psychiatry, Ankara City Hospital, Ankara3Biochemistry, Hatay Training and Research Hospital, Hatay, Türkiye2Psychiatry, Ankara City Hospital, Ankara2Psychiatry, Ankara City Hospital, Ankara2Psychiatry, Ankara City Hospital, Ankara Introduction Although the immune system is thought to contribute to the etiology of schizophrenia, the mechanism has not been clearly elucidated. Clarifying the relationship between them is important in terms of diagnosis, treatment, and prevention approaches. Objectives In this study, it is aimed to determine whether there is any difference in serum levels of neutrophil gelatinase-associated lipocalin (NGAL) and tumor necrosis factor-alpha (TNF-α) in the group of patients with schizophrenia and healthy volunteers, whether these values are changed by medical treatment, whether there is any relation between these values and the severity of the symptoms of patients with schizophrenia, and whether NGAL can be used as a biomarker in the diagnosis and the follow-up of the schizophrenia. Methods A total of 64 patients who were hospitalized in the Psychiatry Clinic of Xxxxxx and diagnosed with schizophrenia and 55 healthy volunteers were included in the study. A sociodemographic information form was given to all participants and TNF-α and NGAL values were measured. Positive and Negative Symptoms Rating Scale (PANSS) were applied to the schizophrenia group on admission and follow-up. TNF-α and NGAL levels were re-measured in the 4th week after the start of antipsychotic treatment. Results As a result of the present study, it was found that NGAL levels decreased significantly after antipsychotic treatment of schizophrenia patients hospitalized with exacerbation (Figure 1). There was no significant correlation between NGAL and TNF-α levels among schizophrenia and the control group. Image: Conclusions In psychiatric diseases, especially schizophrenia, there may be differences in immune and inflammatory markers compared to the healthy population. After treatment, the NGAL levels of the patients at follow-up were reduced in comparison with the levels at their admission. It can be thought that NGAL may be related to psychopathology in schizophrenia and antipsychotic treatment. This is the first followup study for NGAL levels in schizophrenia. Disclosure of Interest A. Gül Çakıl Grant / Research support from: This study funded by the Turkish Republic SBU Scientific Research Projects Coordinatorship. (Project no: 2020/013), H. Kaya: None Declared, A. Sakallı Nural: None Declared, I. Çakmak: None Declared, I. Okay: None Declared, E. Göka: None Declaredhttps://www.cambridge.org/core/product/identifier/S0924933823005825/type/journal_article |
| spellingShingle | A. Gül Çakıl H. Kaya A. Sakallı Nural I. B. Çakmak I. T. Okay E. Göka Neutrophil gelatinase-associated lipocalin (NGAL) and tumor necrosis factor-α(TNF-α) levels in patients with schizophrenia European Psychiatry |
| title | Neutrophil gelatinase-associated lipocalin (NGAL) and tumor necrosis factor-α(TNF-α) levels in patients with schizophrenia |
| title_full | Neutrophil gelatinase-associated lipocalin (NGAL) and tumor necrosis factor-α(TNF-α) levels in patients with schizophrenia |
| title_fullStr | Neutrophil gelatinase-associated lipocalin (NGAL) and tumor necrosis factor-α(TNF-α) levels in patients with schizophrenia |
| title_full_unstemmed | Neutrophil gelatinase-associated lipocalin (NGAL) and tumor necrosis factor-α(TNF-α) levels in patients with schizophrenia |
| title_short | Neutrophil gelatinase-associated lipocalin (NGAL) and tumor necrosis factor-α(TNF-α) levels in patients with schizophrenia |
| title_sort | neutrophil gelatinase associated lipocalin ngal and tumor necrosis factor α tnf α levels in patients with schizophrenia |
| url | https://www.cambridge.org/core/product/identifier/S0924933823005825/type/journal_article |
| work_keys_str_mv | AT agulcakıl neutrophilgelatinaseassociatedlipocalinngalandtumornecrosisfactoratnfalevelsinpatientswithschizophrenia AT hkaya neutrophilgelatinaseassociatedlipocalinngalandtumornecrosisfactoratnfalevelsinpatientswithschizophrenia AT asakallınural neutrophilgelatinaseassociatedlipocalinngalandtumornecrosisfactoratnfalevelsinpatientswithschizophrenia AT ibcakmak neutrophilgelatinaseassociatedlipocalinngalandtumornecrosisfactoratnfalevelsinpatientswithschizophrenia AT itokay neutrophilgelatinaseassociatedlipocalinngalandtumornecrosisfactoratnfalevelsinpatientswithschizophrenia AT egoka neutrophilgelatinaseassociatedlipocalinngalandtumornecrosisfactoratnfalevelsinpatientswithschizophrenia |